Specifically, the tumor-inhibitory effects of rutin have been shown to be exerted through the regulation of various signaling pathways, such as PI3K/Akt/mTOR, NF-κB, Nrf2, ERK, p38 MAPK, and JNK. Here, AKT1 is linked to neoplasm.